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Introduction
Schizophrenia is a disabling psychiatric condition, with high heritability. Recent large scale molecular genetic studies have identified up to 160 common and rare independent loci that increase risk for falling ill with the disease 1, 2 . Schizophrenia risk loci are enriched within synaptic proteins 3 and histone modifiers 4 . There is also emerging evidence implicating risk loci related to the innate immune system 4, 5 . Evidence from epidemiological data 6, 7 and findings showing increased inflammatory factors in the circulation 8 and in post-mortem brain 9 of schizophrenia patients further implicate altered immune function in the development of disease symptoms.
Mechanistic insights linking immune changes to risk for psychopathology are lacking. However, recent interest has focused on microglia, the resident macrophage-like immune cells of the central nervous system, with data suggesting possible alterations in microglial functioning in both diagnosed patients and healthy people at high risk of schizophrenia [10] [11] [12] [13] . The causal mechanism(s) by which microglia might contribute to pathogenesis remain unclear. However, there is increasing evidence that, in addition to canonical immune functions, microglia can also modify neuronal networks through synaptic pruning during development 14 and adulthood 15 and that this microglial-mediated pruning is important for normal brain and behavioural functioning 16 . Additionally, microglia can modulate neuronal firing through direct cell-cell contacts 17 , and have been shown to be capable of phagocytosing both developing 18 and adult 19 neurons.
There is also previous evidence linking postnatal neurogenesis to schizophrenia including changes in cell proliferation and expression of immature neuronal markers in the hippocampus [20] [21] [22] . Adult born hippocampal neurons, up to 700 of which are estimated to be born per day in humans 23 , develop through a well-defined series of cell divisions and differentiations, starting from proliferative stem cells and intermediate progenitors, through migratory neuroblasts and immature neurons, before eventually forming mature granule cells 24 . In rodent models, adult born hippocampal neurons have been shown to be involved in a number of behavioural processes spanning pattern separation 25, 26 , spatial navigation 27, 28 , memory turnover 29 , and acquisition 30 and extinction 31 of fear memory.
Schizophrenia patients show impairments in many of these psychological processes [32] [33] [34] [35] . Furthermore, atypical antipsychotics increase neurogenesis 36 and a number of functionally diverse schizophrenia risk genes, including DISC1
37
, SREB2/GPR85 38 , CACNA1C 39,40 DGCR8
41
, and miR137
42
, modify adult hippocampal neurogenesis in rodent models.
Here we examine the process of postnatal hippocampal neurogenesis using a mouse model of Cyfip1
haploinsufficiency. Cyfip1 is a schizophrenia risk factor through its presence in the 15q11.2(BP1-BP2) copy number deletion. Loss of one copy of this interval leads to substantially increased disease risk in both Western 43, 44 and Han Chinese populations 45 . CYFIP1 haploinsufficiency is likely a key contributor to the 15q11.2(BP1-BP2) psychiatric phenotype due to the established roles of CYFIP1 in synaptic function. CYFIP1 has been shown to be involved in alterations in dendritic spine morphology and branching [46] [47] [48] and furthermore CYFIP1 protein interacts with fragile X mental retardation 1 (FMRP), the protein gene product of FMR1, to suppress translation of up to 800 target transcripts 49 . Alterations in FMR1, causative for Fragile X syndrome, are also associated with a range of psychiatric symptoms 50 .
Additionally, CYFIP1 protein interacts with Wiskott-Aldrich syndrome protein family member 1 (WAVE1), a key mediator of cytoskeleton dynamics, to modulate ARP2/3 dependant actin branching 51 .
In our experiments, we demonstrate a novel function of Cyfip1 in the control of postnatal neurogenesis in the hippocampus. Specifically, we show that Cyfip1 is highly expressed in microglia and is involved in inducing apoptosis of new born immature neuron in a process requiring microglial secreted factors. We also show that this process is gene-dose sensitive and that haploinsufficiency of Cyfip1, recapitulating a genetic risk factor for schizophrenia, impairs the ability of microglia to carry out this function leading ultimately to an excess of mature new born neurons within the dentate gyrus.
These findings provide a novel mechanism linking a penetrant psychiatric risk gene candidate with microglial dysfunction in the hippocampus, a brain area central to disease pathology.
Materials and methods
For full materials and methods, see Supplementary Information. . Free floating 40 μm cryostat sections were used for immunohistochemistry.
Immunohistochemistry was performed as previously described 52 , with a 1:12 stereotactic sampling rate. Detection of cleaved caspase 3 used a modified protocol, where primary antibodies were incubated for 48 h in blocking solution at 4°C. Primary and secondary antibodies are described in table S1.
Primary hippocampal progenitor culture
Hippocampal progenitors were isolated from P7-P8 animals. Isolated hippocampi were dissociated in papain and progenitors were enriched through Optiprep density gradient centrifugation. Cells were cultured on poly-L-lysine and laminin in the presence of EGF and FGF2.
Primary microglial culture
Microglia were isolated from P7-P8 whole brain mixed glia through the shake-off method.
Immunocytochemistry 6
Fixed cultures were blocked and permeabilized with 5% donkey serum and 0.1% Triton X100 in PBS for 30 minutes at room temperature. Primary antibodies were applied in the same solution overnight at 4 °C. Antibodies are detailed in Table S1 . Following three washes in PBST, relevant secondary antibodies were applied in PBST for two hours at room temperature. For identification of microglia, Alexa 568 conjugated IB4 (Thermo Fisher I21412) was added to secondary antibody solutions at 2.5 µg/ml. Cells were washed, counterstained with DAPI, and mounted for microscopy.
Conditioned medium
Microglia conditioned medium was prepared by incubating 5x10 5 microglia per ml in progenitor medium for 24 h. 25% conditioned medium was added to hippocampal cultures. These data indicated that the excess numbers of immature neurons seen in the Cyfip1 +/-animals were maintained into maturation. We found no significant effects of sex of the animal (see fig S1) .
Increased neuronal numbers in Cyfip1 haploinsufficiency is due to decreased apoptosis
To investigate the cell-intrinsic effects of Cyfip1 haploinsufficiency independent of niche effects we used primary hippocampal progenitor cultures. 
Apoptosis of newly born neurons is mediated by microglia secreted factors
Given the known roles microglia play in earlier stages of neurogenesis 53 , we speculated that microglia may play a role in the survival and death of adult new born immature neurons. To test this we first depleted microglia from wildtype primary hippocampal progenitor cultures using the specific microglia toxin Mac-1-SAP, targeting CD11b expressing cells. We established the presence of microglia in the culture system ( fig S3) and the efficacy of the toxin against primary mouse microglia (fig 3a) . found with respect to any of the molecules we were able to assay (full list of analytes in Table S2 and full statistics in Table S3 ). fig 5f) with post hoc analysis confirming the wildtype stimulated condition was significantly different from the unconditioned medium controls and Cyfip1 +/-stimulated condition (p=0.007 and p=0.005, respectively). As before, no effect of any of the medium conditions was seen on the nestinpositive population (64.7±2.6% vs 64.0±2.3% vs 57.5±3.3%, F(2,9)=2.13, p=0.18, fig 5f) . These data provide converging evidence for induction of neuronal apoptosis through factors secreted by microglia, a process which is disrupted in Cyfip1 +/-animals.
Discussion
The immune system has been implicated in risk for schizophrenia [6] [7] [8] [9] . Here we have demonstrated a previously unknown link between microglia, the resident immune cells in the brain, and haploinsufficiency of a genetic risk candidate for schizophrenia, Cyfip1. We report that Cyfip1
animals have larger numbers of surviving newly born neurons in hippocampus, in the absence of increases in numbers of stem cells or rate of proliferation, and provide evidence that this is the result of a specific failure in microglia-induced neuronal apoptosis (see summary of proposed mechanism in fig 5i) . Our data are consistent with a novel role for microglia in controlling adult hippocampal neurogenesis, a cellular process with a suggested role in the symptomatology of schizophrenia and other psychiatric diseases 54 .
Despite recent debate regarding the extent to which adult hippocampal neurogenesis occurs in humans 55 , revolving largely around the use of different cellular markers, the location, cell types and numbers involved in this process have now been well characterised though several different means 23, 56 . Although we have used P7-P8 animals to generate sufficient primary cells, by this stage the niche organisation and marker expression patterns are comparable to adults 57 . The large degree of cross-over between in vivo and in vitro approaches strongly suggests the data obtained in the culture systems are applicable to in vivo adult neurogenesis.
Our study is the first to demonstrate a direct effect of microglial soluble factors on the survival of immature neurons as a homeostatic mechanism. In contrast to earlier findings examining the effect of microglia on adult neurogenesis [58] [59] [60] , we show this occurs in the absence of overt inflammatory disease or microglial activation. Nonetheless, our data indicate this is a mechanism susceptible to pathogenic changes as evidenced by the effects of Cyfip1 haploinsufficiency on the ability of microglia to regulate apoptosis of immature neurons. Importantly, the inability of Cyfip1 +/-microglia to induce neuronal apoptosis seems to be a specific deficit, rather than as a result of generalised microglial dysfunction. We showed a mild activation deficit as measured by CD68 levels in Cyfip1 +/-microglia. In our case however, overall secretion of cytokines and chemokines, both at baseline and following activation, was unaffected. This suggests that, whilst Cyfip1 is strongly up-regulated following activation, and it may play some role during the response to inflammatory stimuli, it is not crucial for a robust immune response in microglia.
The failure of neurons to enter microglia-induced apoptosis under conditions of Cyfip1 haploinsufficiency could be due to a failure of the microglia to induce the apoptosis, or a failure of neurons to respond appropriately, or both. However, the fact that conditioned medium from wildtype microglia was able to induce apoptosis in Cyfip1 +/-microglia demonstrates unequivocally that these neurons are capable of responding to soluble pro-apoptotic signals, and the primary deficit is in the microglia, not the neurons. Moreover, the inability of Cyfip1 +/-microglia conditioned medium to induce apoptosis further confirmed the deficit is in the microglia not the neurons. There is also the possibility of the Cyfip1 +/-microglia secreting higher levels of anti-apoptotic factors, rather than failing to secrete pro-apoptotic factors. However, this does not fit our data as were this to be the case we would expect a decrease in apoptosis in wild-type cultures exposed to conditioned medium from Cyfip1 +/-microglia, which we did not observe.
We have demonstrated that soluble factors from microglia are involved in controlling numbers of immature neurons, and that haploinsufficiency of Cyfip1 leads to reduced apoptosis via an effect on factors secreted from microglia, however the soluble factor(s) responsible remain to be identified.
Cyfip1 has numerous pleotropic effects and it is known that the types of actin remodelling Cyfip1 can influence is involved in cytokine secretion 61 . However, no genotype difference in secreted levels of a number of common cytokines and chemokines was apparent and further work is needed to identify the soluble factor(s) involved in the altered molecular signalling between microglia and developing new born neurons.
The effects of Cyfip1 haploinsufficiency were highly cell-type specific and appeared limited to the stage of cell maturity where neuronal progenitors are fully committed to a neuronal phenotype, a stage of development characterised by high levels of apoptosis (see figure 5i) . However, the increase in surviving neurons we observed persisted for up to at least 30 days post-division, at which point, given the expression of the mature neuronal marker NeuN, it is highly likely these cells have integrated into the local circuitry. Indeed, it is known that at 30 days of maturity, newly born neurons are already connected to the local granule cell population 62 . Consequently, it is possible that functional effects on brain and behaviour could be exerted at several points along the developmental pathway from the immature neuron stage to the fully integrated mature granule cell in the dentate gyrus. Studies which are able to track the electrophysiological and other functional properties of Cyfip1 +/-adult born neurons as they differentiate, migrate, and form synaptic contacts would be required to answer this question.
It is becoming increasingly evident that microglia play multiple roles in brain function beyond their involvement in classical immune homeostasis. Our findings identify a novel mechanism by which microglia are involved in the regulation of hippocampal neurogenesis in a process that is disrupted by Cyfip1 haploinsufficiency, leading to an excess of adult born neurons. The 15q11.2(BP1-BP2) deletion
is not solely associated with schizophrenia, it also markedly increases risk for autism spectrum disorders 63 , ADHD and developmental delay 64 , and epilepsy 65 . Whether altered microglia functioning due to Cyfip1 haploinsufficiency, impacting on adult hippocampal neurogenesis, also plays a part in these disorders is an open question, but all have been associated with alterations in immune system and microglia functioning 66, 67 . Moreover, as noted previously, a number of schizophrenia risk genes, shows the distribution of microglia in the dentate gyrus. b) Quantification of microglial numbers showed no significant genotype differences (WT n=5, Cyfip1 +/-n=8. c) Quantitative PCR for Cyfip1 transcript in wildtype primary microglia showed a highly significant upregulation following activation by 10 µg/ml LPS (n=3 each). d) Cyfip1 +/-primary microglia showed a significant activation deficit, as measured by CD68 levels. e) No significant effects of genotype in levels of microglia secreted factors in culture medium assayed using the Luminex TM system at baseline and following activation with LPS (n=10 for all conditions). All data are shown as mean±SEM. 
